{"product_id":"whistleblowers-isbn-9781118094037","title":"Whistleblowers","description":"\u003cb\u003eSolid guidance for managing whistleblower policies in light of the new Dodd-Frank Act provisions\u003c\/b\u003e  \u003cp\u003eIn July 2010, President Obama signed the Dodd-Frank Wall Street Reform and Consumer Protection Act that greatly expanded whistleblower bounties in connection with violations of federal securities laws, including the Foreign Corrupt Practices Act. Discussing business protection strategies and best practices in dealing with whistleblowers, Whistleblowers will appeal to board members, executives, corporate compliance personnel, attorneys for whistleblowers and defense attorneys, as well as potential employee whistleblowers.\u003c\/p\u003e \u003cul\u003e \u003cli\u003eCase studies of GlaxoSmithKline, Pfizer and other high profile whistleblower incidences\u003c\/li\u003e \u003cli\u003eExamines new Dodd-Frank incentives to whistleblowers\u003c\/li\u003e \u003cli\u003eRecommends best practices for corporations in light of new whistleblowing incentives\u003c\/li\u003e \u003cli\u003eExplores other federal and state statutory incentives to whistleblowing\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003eTimely and comprehensive, \u003ci\u003eWhistleblowers\u003c\/i\u003e emphasizes the disincentives to whistleblowing, reviewing the academic studies of whistleblowers with the idea of developing best practices in working with whistleblowers.\u003c\/p\u003e  Foreword xiii  \u003cp\u003eAcknowledgments xv\u003c\/p\u003e \u003cp\u003eIntroduction 1\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePART I: THE WHISTLEBLOWERS AND THE DODD-FRANK INCENTIVES\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 1: The Dramatic Expansion of Whistleblower Awards under Dodd-Frank 11\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eWhistleblower Provisions of Dodd-Frank 13\u003c\/p\u003e \u003cp\u003eWhat Is “Original Information”? 14\u003c\/p\u003e \u003cp\u003eWhat Are Violations of the Federal Securities Laws? 15\u003c\/p\u003e \u003cp\u003eRule 10b-5: Market Manipulation 19\u003c\/p\u003e \u003cp\u003eViolating the Accounting Standards 20\u003c\/p\u003e \u003cp\u003eFalse Financial Statements by Public Companies 20\u003c\/p\u003e \u003cp\u003eOther Securities Laws 22\u003c\/p\u003e \u003cp\u003eProtections for Whistleblowers 23\u003c\/p\u003e \u003cp\u003eCommodity Exchange Act 23\u003c\/p\u003e \u003cp\u003eNotes 25\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 2: The Remarkable Story of Cheryl Eckard and the $96 Million Bounty under the False Claims Act 27\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eWho Is Cheryl Eckard? 27\u003c\/p\u003e \u003cp\u003eEckard’s Post-termination Activities 28\u003c\/p\u003e \u003cp\u003eEckard’s Superiors 29\u003c\/p\u003e \u003cp\u003eBackground Allegations 30\u003c\/p\u003e \u003cp\u003eAlleged Violations 31\u003c\/p\u003e \u003cp\u003eTimeline of Eckard’s Alleged Activities 33\u003c\/p\u003e \u003cp\u003eThe Lessons of Glaxo 40\u003c\/p\u003e \u003cp\u003eNotes 42\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 3: The Pfi zer Whistleblowers Who Collected Over $100 Million under the False Claims Act 45\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eJohn Kopchinski 46\u003c\/p\u003e \u003cp\u003eBextra 47\u003c\/p\u003e \u003cp\u003eThe Complaint 48\u003c\/p\u003e \u003cp\u003ePfizer Lessons 51\u003c\/p\u003e \u003cp\u003eNotes 53\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePART II: DISINCENTIVES AND FACTORS MOTIVATING PUBLIC DISCLOSURE\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 4: Disincentives to Internal Whistleblowers 57\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eFinancial Disincentives 58\u003c\/p\u003e \u003cp\u003eNonfi nancial Disincentives 59\u003c\/p\u003e \u003cp\u003eContractual Commitments and Fiduciary Duties 60\u003c\/p\u003e \u003cp\u003eEthics Resource Center Survey 61\u003c\/p\u003e \u003cp\u003eReinstatement as a Remedy 62\u003c\/p\u003e \u003cp\u003eEmpirical Study 65\u003c\/p\u003e \u003cp\u003eNotes 67\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 5: Women as Whistleblowers: Factors Motivating Public Whistleblowing 69\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eSherron Watkins 69\u003c\/p\u003e \u003cp\u003eCynthia Cooper 71\u003c\/p\u003e \u003cp\u003eColeen Rowley 71\u003c\/p\u003e \u003cp\u003eExternal Reporting by Internal Whistleblowers 72\u003c\/p\u003e \u003cp\u003eWhistleblower Anonymity 74\u003c\/p\u003e \u003cp\u003eNotes 74\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePART III: ORGANIZATIONAL BEST PRACTICES\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 6: Why Should Organizations Adopt a Robust Whistleblower System? 79\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eDiminishment of Shareholder Wealth 80\u003c\/p\u003e \u003cp\u003eBoards of Directors 81\u003c\/p\u003e \u003cp\u003eWe Were Duped! 82\u003c\/p\u003e \u003cp\u003eExecutive Whistleblowers 84\u003c\/p\u003e \u003cp\u003eWhy Independent Directors Cannot Rely Solely on Independent or Internal Auditors 86\u003c\/p\u003e \u003cp\u003eLegal Standard 89\u003c\/p\u003e \u003cp\u003e\u003ci\u003eCaremark\u003c\/i\u003e 90\u003c\/p\u003e \u003cp\u003eRecommended Strategy 91\u003c\/p\u003e \u003cp\u003eCriminal Liability of an Organization 92\u003c\/p\u003e \u003cp\u003eResponsible Corporate Officer Doctrine 93\u003c\/p\u003e \u003cp\u003eThe \u003ci\u003eAcme Markets\u003c\/i\u003e Case 94\u003c\/p\u003e \u003cp\u003eThe U.S. Department of Justice Criminal Guidelines 96\u003c\/p\u003e \u003cp\u003eThe Disadvantages of a Robust Whistleblower System 97\u003c\/p\u003e \u003cp\u003eNotes 98\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 7: Establishing a Robust Whistleblower System 103\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eProblems with the Current Whistleblower System 104\u003c\/p\u003e \u003cp\u003eInitial Steps 107\u003c\/p\u003e \u003cp\u003eElements of a Robust Whistleblower Policy 108\u003c\/p\u003e \u003cp\u003eIndependent Directors Must Be in Charge 109\u003c\/p\u003e \u003cp\u003eThe Whistleblower Program Must Be Independently Administered 111\u003c\/p\u003e \u003cp\u003eWhistleblower Complaints Should be Investigated by Independent Counsel Reporting Directly to the Independent Directors 113\u003c\/p\u003e \u003cp\u003eThere Should Be No Presumption that Anonymous Complaints Are Less Deserving of Investigation 117\u003c\/p\u003e \u003cp\u003eMotivations and Personality of the Whistleblower Are Not Relevant to the Truth of the Allegations 118\u003c\/p\u003e \u003cp\u003eAbsolute Protection of Whistleblowers’ Identity Is Essential 119\u003c\/p\u003e \u003cp\u003eAssess the Effectiveness of Hotlines and Provide Employee Compliance Training 123\u003c\/p\u003e \u003cp\u003eIndependent Counsel Should Report the Status and Results of the Investigation 124\u003c\/p\u003e \u003cp\u003eInternal Whistleblowers Should Receive Meaningful Monetary Rewards 125\u003c\/p\u003e \u003cp\u003eThe Whistleblower Policy Must Be Communicated Effectively 127\u003c\/p\u003e \u003cp\u003eThere Should Be Milder Sanctions for Whistleblowers Involved in Illegal Group Activity 130\u003c\/p\u003e \u003cp\u003eRetaliation Claims Should Be Independently Investigated 131\u003c\/p\u003e \u003cp\u003eThe Director of Corporate Compliance Should Become the Eyes and Ears of the Independent Directors 132\u003c\/p\u003e \u003cp\u003eMajor Dos and Don’ts for CEOs 134\u003c\/p\u003e \u003cp\u003eNotes 135\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePART IV: STATUTORY INCENTIVES AND SEC AWARD REGULATIONS\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 8: The False Claims Act: Qui Tam Cases 141\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eWhat Is a False Claim? 142\u003c\/p\u003e \u003cp\u003eFalse Claims Act Bounties 144\u003c\/p\u003e \u003cp\u003eU.S. Department of Justice Memorandum 146\u003c\/p\u003e \u003cp\u003eStatute of Limitations 149\u003c\/p\u003e \u003cp\u003eNotes 150\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 9: IRS Whistleblowers 153\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eSection 7623(b): Mandatory Whistleblower Awards 155\u003c\/p\u003e \u003cp\u003eReduction of Award Percentage 156\u003c\/p\u003e \u003cp\u003eSection 7623(a): Discretionary Awards 157\u003c\/p\u003e \u003cp\u003eForm 211 158\u003c\/p\u003e \u003cp\u003eIRS Whistleblowers Awards 159\u003c\/p\u003e \u003cp\u003eIRS Award Determinations 160\u003c\/p\u003e \u003cp\u003eAward Administrative Proceedings 162\u003c\/p\u003e \u003cp\u003eAppeal to Tax Court 164\u003c\/p\u003e \u003cp\u003eDuration of Process and Award Payment 164\u003c\/p\u003e \u003cp\u003eConfi dentiality of Whistleblower 165\u003c\/p\u003e \u003cp\u003eRight to Counsel 165\u003c\/p\u003e \u003cp\u003eIRS Contracts 165\u003c\/p\u003e \u003cp\u003eDisqualifi cation of U.S. Treasury Department Federal Employees 166\u003c\/p\u003e \u003cp\u003eNotes 167\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 10: Other Statutory Incentives and Protections for Whistleblowers 169\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eAct to Prevent Pollution from Ships 169\u003c\/p\u003e \u003cp\u003eFalse Patent Marking Statute 170\u003c\/p\u003e \u003cp\u003eU.S. Tariff Act of 1930 172\u003c\/p\u003e \u003cp\u003eState False Claims Statutes 173\u003c\/p\u003e \u003cp\u003eWhistleblower Protections 179\u003c\/p\u003e \u003cp\u003e\u003ci\u003eBarker v. UBS\u003c\/i\u003e 180\u003c\/p\u003e \u003cp\u003eOther Statutory Whistleblower Protections 185\u003c\/p\u003e \u003cp\u003eNotes 186\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 11: A Step-by-Step Guide to SEC Whistleblowers Awards under Dodd-Frank 189\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eSummary 190\u003c\/p\u003e \u003cp\u003eSEC Investor Protection Fund 194\u003c\/p\u003e \u003cp\u003eDoes the Whistleblower Need an Attorney? 195\u003c\/p\u003e \u003cp\u003eStep-by-Step Guide 196\u003c\/p\u003e \u003cp\u003eDetermining Whether the Over $1 Million Threshold Is 202\u003c\/p\u003e \u003cp\u003eSatisfied Determining the Amount of an Award 202\u003c\/p\u003e \u003cp\u003eMust an Employee Comply with the Company’s Internal Compliance Program? 204\u003c\/p\u003e \u003cp\u003eConfidentiality 205\u003c\/p\u003e \u003cp\u003eNonwaiver of Whistleblower Rights 205\u003c\/p\u003e \u003cp\u003eAppeals 205\u003c\/p\u003e \u003cp\u003eAnti-retaliation Provision 206\u003c\/p\u003e \u003cp\u003eNotes 206\u003c\/p\u003e \u003cp\u003eAppendix 1: IRS Form 211 207\u003c\/p\u003e \u003cp\u003eAppendix 2: SEC Form TCR: Tip, Complaint or Referral 211\u003c\/p\u003e \u003cp\u003eAppendix 3: SEC Form WB-APP: Application for Award for Original Information Submitted Pursuant to Section 21F of the Securities Exchange Act of 1934 229\u003c\/p\u003e \u003cp\u003eAppendix 4: SEC Whistleblower Rules 239\u003c\/p\u003e \u003cp\u003eAbout the Author 265\u003c\/p\u003e \u003cp\u003eIndex 267\u003c\/p\u003e   \u003cp\u003e\u003cb\u003eFREDERICK D. LIPMAN\u003c\/b\u003e is a partner with the international law firm of Blank Rome LLP and is also the president of the Association of Audit Committee Members, Inc. He has more than fifty years of experience in the areas of corporate governance, mergers and acquisitions, private equity, and IPOs. He has appeared on CNBC, CNN, Bloomberg, and Chinese television as a national commentator on business topics and has been quoted in the Wall Street Journal, the New York Times, USA Today, Forbes, and other business publications.    \u003c\/p\u003e\u003cp\u003e\u003cb\u003eWHISTLEBLOWERS\u003c\/b\u003e \u003c\/p\u003e\u003cp\u003e\u003cb\u003eIncentives, Disincentives, and Protection Strategies\u003c\/b\u003e \u003c\/p\u003e\u003cp\u003e\"It becomes clearer than ever before that rules and regulations relating to whistleblowing are changing, becoming ever-pervasive and affecting a multitude of industries . . . Step by step, as a wise and learned guide, Mr. Lipman takes us through the legislation and institutional frameworks allowing whistleblowers a voice . . . I encourage you to begin this journey into whistleblowing law. From stories of outstanding whistleblowers, analysis of the Dodd-Frank reforms, and other whistleblowing statutes including those relating to the IRS, to best practices in dealing with whistleblowers, to providing whistleblowers with appropriate forms to submit information to the SEC, Fred Lipman leaves no stone unturned in his A-to-Z account of whistleblower law in the United States.\" \u003cb\u003e–From the Foreword by Dr. Gaytri D. Kachroo, Esq., Contributor to No One Would Listen by Harry Markopolos\u003c\/b\u003e \u003c\/p\u003e\u003cp\u003eA timely and much-needed resource guiding businesses in managing their whistleblower policies in light of the new Dodd-Frank Act provisions, Whistleblowers: Incentives, Disincentives, and Protection Strategies shines a light on a topic that, until now, has been the pink elephant in the corporate boardroom. Critically examining current deterrents to whistleblowing, author Frederick Lipman reviews academic studies of whistleblowers and offers best practices for working with them. \u003c\/p\u003e\u003cp\u003eWhistleblowers provides you—whether you are a board member, C-suite executive, corporate compliance officer, attorney for whistleblowers, defense attorney, or even a potential employee whistleblower—with essential business protection strategies, as well as a look at: \u003c\/p\u003e\u003cul\u003e \u003cli\u003eThe dramatic expansion of whistleblower awards under Dodd-Frank\u003c\/li\u003e \u003cli\u003eHigh-profile case studies, including the remarkable story of Cheryl Eckard and the $96 million bounty under the False Claims Act\u003c\/li\u003e \u003cli\u003eDisincentives to internal whistleblowers\u003c\/li\u003e \u003cli\u003eWomen as whistleblowers: Sherron Watkins, Cynthia Cooper, Coleen Rowley\u003c\/li\u003e \u003cli\u003eWhy your organization must adopt a robust whistleblower system\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003eIt's the tone set at the top of an organization that impacts its corporate culture. Unfortunately, too often senior management and boards in public and private companies insulate themselves from information, to their own detriment. Sending a powerful message to U.S. corporations to seriously overhaul their compliance measures, Whistleblowers is a necessary guide, serving as a beacon for whistleblowers and their managers in presenting complaints—and staying the course.\u003c\/p\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":47990484762853,"sku":"NP9781118094037","price":65.0,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9781118094037.jpg?v=1761788013","url":"https:\/\/k12savings.com\/products\/whistleblowers-isbn-9781118094037","provider":"K12savings","version":"1.0","type":"link"}